Genetic Risk for Attention-Deficit/Hyperactivity Disorder Predicts Cognitive Decline and Development of Alzheimer’s Disease Pathophysiology in Cognitively Unimpaired Older Adults
View ORCID ProfileDouglas T. Leffa, View ORCID ProfileJoão Pedro Ferrari-Souza, Bruna Bellaver, Cécile Tissot, Pamela C. L. Ferreira, Wagner S. Brum, Arthur Caye, View ORCID ProfileJodie Lord, View ORCID ProfilePetroula Proitsi, Thais Martins-Silva, Luciana Tovo-Rodrigues, Dana L. Tudorascu, Victor L. Villemagne, Annie Cohen, Oscar L. Lopez, William E. Klunk, Thomas K. Karikari, Pedro Rosa-Neto, Eduardo Zimmer, Brooke S.G. Molina, Luis Augusto Rohde, Tharick A. Pascoal, the Alzheimer’s Disease Neuroimaging Initiative
doi: https://doi.org/10.1101/2022.04.05.22273464
Douglas T. Leffa
1ADHD Outpatient Program & Development Psychiatry Program, Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil
2Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
M.D., Ph.D.João Pedro Ferrari-Souza
2Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
3Graduate Program in Biological Sciences: Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil
Bruna Bellaver
2Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
3Graduate Program in Biological Sciences: Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil
Ph.D.Cécile Tissot
2Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
4Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer’s Disease Research Unit, Douglas Research Institute, Le Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l’Ouest-de-l’Île-de-Montréal, and Departments of Neurology, Neurosurgery, Psychiatry, Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada
Pamela C. L. Ferreira
2Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
Ph.D.Wagner S. Brum
3Graduate Program in Biological Sciences: Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil
5Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Arthur Caye
1ADHD Outpatient Program & Development Psychiatry Program, Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil
11National Institute of Developmental Psychiatry for Children and Adolescents, São Paulo, Brazil
M.D., Ph.D.Jodie Lord
6Institute of Psychology, Psychiatry & Neuroscience, King’s College London, London, United Kingdom
MScPetroula Proitsi
6Institute of Psychology, Psychiatry & Neuroscience, King’s College London, London, United Kingdom
PhDThais Martins-Silva
7Human Development and Violence Research Centre (DOVE), Post-Graduate Program in Epidemiology, Universidade Federal de Pelotas, Pelotas, Rio Grande do Sul, Brazil
PhDLuciana Tovo-Rodrigues
8Postgraduate Program in Epidemiology, Universidade Federal de Pelotas, Pelotas, Rio Grande do Sul, Brazil
PhDDana L. Tudorascu
2Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
Ph.D.Victor L. Villemagne
2Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
M.D.Annie Cohen
2Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
Ph.D.Oscar L. Lopez
9Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA
M.D.William E. Klunk
2Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
9Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA
M.D., Ph.D.Thomas K. Karikari
2Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
5Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Ph.D.Pedro Rosa-Neto
4Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer’s Disease Research Unit, Douglas Research Institute, Le Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l’Ouest-de-l’Île-de-Montréal, and Departments of Neurology, Neurosurgery, Psychiatry, Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada
M.D., Ph.D.Eduardo Zimmer
10Department of Pharmacology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil
Ph.D.Brooke S.G. Molina
2Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
Ph.D.Luis Augusto Rohde
1ADHD Outpatient Program & Development Psychiatry Program, Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil
11National Institute of Developmental Psychiatry for Children and Adolescents, São Paulo, Brazil
M.D., Ph.D.Tharick A. Pascoal
2Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
9Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA
M.D., Ph.D.![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Posted April 07, 2022.
Genetic Risk for Attention-Deficit/Hyperactivity Disorder Predicts Cognitive Decline and Development of Alzheimer’s Disease Pathophysiology in Cognitively Unimpaired Older Adults
Douglas T. Leffa, João Pedro Ferrari-Souza, Bruna Bellaver, Cécile Tissot, Pamela C. L. Ferreira, Wagner S. Brum, Arthur Caye, Jodie Lord, Petroula Proitsi, Thais Martins-Silva, Luciana Tovo-Rodrigues, Dana L. Tudorascu, Victor L. Villemagne, Annie Cohen, Oscar L. Lopez, William E. Klunk, Thomas K. Karikari, Pedro Rosa-Neto, Eduardo Zimmer, Brooke S.G. Molina, Luis Augusto Rohde, Tharick A. Pascoal, the Alzheimer’s Disease Neuroimaging Initiative
medRxiv 2022.04.05.22273464; doi: https://doi.org/10.1101/2022.04.05.22273464
Genetic Risk for Attention-Deficit/Hyperactivity Disorder Predicts Cognitive Decline and Development of Alzheimer’s Disease Pathophysiology in Cognitively Unimpaired Older Adults
Douglas T. Leffa, João Pedro Ferrari-Souza, Bruna Bellaver, Cécile Tissot, Pamela C. L. Ferreira, Wagner S. Brum, Arthur Caye, Jodie Lord, Petroula Proitsi, Thais Martins-Silva, Luciana Tovo-Rodrigues, Dana L. Tudorascu, Victor L. Villemagne, Annie Cohen, Oscar L. Lopez, William E. Klunk, Thomas K. Karikari, Pedro Rosa-Neto, Eduardo Zimmer, Brooke S.G. Molina, Luis Augusto Rohde, Tharick A. Pascoal, the Alzheimer’s Disease Neuroimaging Initiative
medRxiv 2022.04.05.22273464; doi: https://doi.org/10.1101/2022.04.05.22273464
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (664)
- Anesthesia (179)
- Cardiovascular Medicine (2603)
- Dermatology (218)
- Emergency Medicine (392)
- Epidemiology (12143)
- Forensic Medicine (10)
- Gastroenterology (752)
- Genetic and Genomic Medicine (4036)
- Geriatric Medicine (380)
- Health Economics (672)
- Health Informatics (2608)
- Health Policy (995)
- Hematology (359)
- HIV/AIDS (833)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (427)
- Neurology (3807)
- Nursing (208)
- Nutrition (567)
- Oncology (1991)
- Ophthalmology (578)
- Orthopedics (235)
- Otolaryngology (303)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (470)
- Pediatrics (1100)
- Primary Care Research (443)
- Public and Global Health (6476)
- Radiology and Imaging (1379)
- Respiratory Medicine (867)
- Rheumatology (395)
- Sports Medicine (337)
- Surgery (438)
- Toxicology (52)
- Transplantation (185)
- Urology (165)